Delgado DD

Language: Spanish
References: 20
Page: 633-636
PDF size: 149.07 Kb.

ABSTRACT

The rate of thyroid cancer has increased in recent years and it is more common in women. Although their etiologies has not been able to be documented accurately, it is known that radiation is a major cause. Most of these pathologies are due to papillary cancer which has a very good prognosis. Furthermore, fine needle biopsy is the main method for diagnosis. The treatment is based on surgery and treatment with radioactive iodine as a second line.

REFERENCES

1. Abu-Ghanem S, Cohen O, Lazutkin A, Abu-Ghanem Y, Fliss D,y Yehuda M. (2015). “Evaluation of clinical presentation and referral indications for ultrasound-guided fine-needle aspiration biopsy of the thyroid as posible predictors of thyroid cancer”. Head & neck. pag 1-5 DOI: 10.1002/ hed.24143

2. Arteaga M, García P. “Embriología Humana y Biología del desarrollo”. 1era edición. Editorial Médica Panamericana. 2014. México D.F. pag

3. Brito J, Davies L. (2014). “Is there an increased incidence of thyroid cancer?”. Current Opinion in Endocrinology, Diabetes and Obesity. 21(5): 405-408

4. Casciato D, Territo Mary. “Manual de Oncología Clínica”. 7ma edición. Lippincott Williams & Wilkins. España. 2014. pag 414-419

5. Clayman G. (2015). “Local Treatment of Differentiated Thyroid Carcinoma”. Clinical advances in Hematology & Oncology. 13(4):6-8

6. Devita V, Lawrence T, Rosenberg S. “Devita, Hellman and Rosenberg´s Cancer Principles & Practice of Oncology”. 10th edition. Wolters Kluwer Health. USA .2015. pag 1175-1187

7. Díez J, Grande E, Iglesias P. (2015). “Ablación posquirúrgica con radioyodo en pacientes con carcinoma diferenciado de tiroides de bajo riesgo”. Elsevier, Medicina Clínica. 144(1): 35-41

8. Galefré J, Chacón A, Latif R. (2013). “Targeting thyroid diseases with TSH receptor analogs”. Elsevier, Endocrinología y nutrición. 60(10): 590-598

9. Ganong W et al. “Ganong Fisiología médica”. 23 edición. McGraw-Hill Interamericana editores. México D.F. pag 301-313

10. González C, Yaniskowski M, Wyse E, Giovannini A, López M, Wior M. (2006). “Cáncer de tiroides”. Medicina (Buenos Aires). 66(6):526- 532

11. González H, Mosso L. (2006). “Cáncer papilar de tiroides: visión actual”. Pontificia Universidad Católica de Chile. Boletin Escuela Medicina. 31(2): 87-91

12. O´Connell L, Prichard R, O´Reilly E, Skehan S, Gibbons D, McDermott E. (2015). “Runnig in the family: A rare diagnosis of familial papillary thyroid”. Elsevier, International Journal of Surgery Case Reports. 16: 64-66

13. Ross M, Pawlina W. “Histología”. 5ta edición. Editorial Médica Panamericana. España, Madrid. 2006. pag 753-758

14. Shah J. (2015). “Thyroid Carcinoma: Epidemiology, Histology, and Diagnosis”. Clinical advances in Hematology & Oncology. 13(4): 3-5

15. Skeel R, Khlief S. “Manual de quimioterapia del cáncer”. 8ª edición. Lippincott Williams & Wilkins. Barcelona España. 2012. pag 258-268

16. Smallridge C, Ain K, Asa S, et al. (2012). “American Thyroid Association Guidelines for management of patients with anaplastic thyroid cancer”. Thyroid,22(11): 1104-1139. DOI: 10.1089/thy.2012.0302

17. Tena M, Rembao D, Salinas C, Vega R, Castillejos M. (2011). “Cuerpos de psamoma y cambios degenerativos de tumores en los plexos coroideos. Estudio clínicopatológico”. Patología Revista latinoamericana. 49(2): 107-114

18. Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F,y Negri E. (2014). “Thyroid cancer mortality and incidence: A global overview”. International Journal of Cancer.136. pag 2187-2195. DOI: 10.1002/ijc.29251

19. Wirth L. (2015). “Targeted Therapy for Advanced or Metastatic Differentiated Thyroid Carcinoma”. Clinical advances in Hematology & Oncology. 13(4): 9-16

20. Yeganeh M, Sheikholeslami S, Hedayati M. (2015). “ RET Proto Oncogen Mutation Detection and Medullary Thyroid Carcinoma Prevention”. Asian Pacific Journal of Cancer Prevention 16(6): 2107- 2117.